Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma.
Clinical trial NCT01777776 · TERMINATED
Trial details
- NCT number
- NCT01777776
- Sponsor
- Array BioPharma
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2015-04-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.